about
Hematopoietic Cell Transplantation Using Reduced-Intensity Conditioning Is Successful in Children with Hematologic Cytopenias of Genetic Origin.Diamond-blackfan anemia and cyclosporine therapy revisited.Health-Related Quality of Life in Survivors of High-Risk Neuroblastoma After Stem Cell Transplant: A National Population-Based Perspective.Infantile choriocarcinoma. Re-examination of a potentially curable entity.High-dose melphalan, etoposide, total-body irradiation, and autologous stem-cell reconstitution as consolidation therapy for high-risk Ewing's sarcoma does not improve prognosis.Improving patient safety by design -- a new spinal/intrathecal injection safety system.Non-resectable congenital tumors with the ETV6-NTRK3 gene fusion are highly responsive to chemotherapy.Successful clinical treatment and functional immunological normalization of human MALT1 deficiency following hematopoietic stem cell transplantationDETECTION OF A NOVEL NONSENSE MUTATION IN THE INTERLEUKIN 2 RECEPTOR γ GENE CAUSING X-LINKED SEVERE COMBINED IMMUNODEFICIENCYErythropoietin therapy in neonates at risk of having bronchopulmonary dysplasia and requiring multiple transfusionsSecond malignancy following high-dose therapy and autologous stem cell transplantation: incidence and risk factor analysisOutcomes of Measurable Residual Disease in Pediatric Acute Myeloid Leukemia before and after Hematopoietic Stem Cell Transplant: Validation of Difference from Normal Flow Cytometry with Chimerism Studies and Wilms Tumor 1 Gene ExpressionSCID genotype and 6-month posttransplant CD4 count predict survival and immune recoveryIfosfamide, gemcitabine, and vinorelbine is an effective salvage regimen with excellent stem cell mobilization in relapsed or refractory pediatric Hodgkin lymphoma
P50
Q33421705-5A9399D3-306E-4693-9C9E-2DAC3416E459Q33898019-8A92066C-1108-4F98-BC22-A1E5756B68D8Q39749852-AB36731C-A568-416F-9108-08D7D21CADA6Q40842632-96ECB034-647B-490A-9518-58B396CBB652Q43626751-F7EE1B6E-3E29-42CE-BDDC-A42209B9F300Q48739162-B7C9EAE9-37B2-4121-B394-E94B14EED3C6Q54782784-128DB092-AE11-4DC1-9946-4A1C6C6A497BQ59093969-2C878410-FA0C-43D0-9B7E-0567F41DDCDBQ60700609-147F0E57-BA2E-437F-8BB5-9218EE661BBDQ71397290-90C1AE20-BEF4-4BE8-A6A4-A3A64DD0C3E4Q79172255-7D65EA0E-CF31-4701-BD69-93D772E658FAQ89187642-4EB301D3-3D70-44D8-A70F-9BE0934D44A0Q91183029-B0BAC77E-2C2D-4F4E-8A47-DA0B1CA626A3Q92568419-1789CE93-9DAD-428D-8DDF-CD088FAFEA9E
P50
description
researcher ORCID ID = 0000-0002-5959-7345
@en
wetenschapper
@nl
name
Jeffrey Davis
@ast
Jeffrey Davis
@en
Jeffrey Davis
@es
Jeffrey Davis
@nl
type
label
Jeffrey Davis
@ast
Jeffrey Davis
@en
Jeffrey Davis
@es
Jeffrey Davis
@nl
prefLabel
Jeffrey Davis
@ast
Jeffrey Davis
@en
Jeffrey Davis
@es
Jeffrey Davis
@nl
P31
P496
0000-0002-5959-7345